BRIM Biotechnology, Inc. (TPE:6885)
Taiwan · Delayed Price · Currency is TWD 20.70
0.00 (0.00%)
At close: May 29, 2026
BRIM Biotechnology Market Cap
BRIM Biotechnology has a market cap or net worth of 2.76 billion as of May 29, 2026. Its market cap has decreased by -10.93% in one year.
Market Cap
2.76B
Enterprise Value
1.79B
Revenue
8.21M
Ranking
n/a
PE Ratio
n/a
Stock Price
20.70
Market Cap Chart
Since June 23, 2022, BRIM Biotechnology's market cap has increased from 1.77B to 2.76B, an increase of 56.15%. That is a compound annual growth rate of 11.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2026 | 2.76B | -30.42% |
| Dec 31, 2025 | 3.96B | -2.58% |
| Dec 31, 2024 | 4.07B | 17.34% |
| Dec 29, 2023 | 3.47B | -2.55% |
| Dec 30, 2022 | 3.56B | 101.45% |
| Jun 23, 2022 | 1.77B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SYN-TECH Chem. & Pharm. | 3.18B |
| Chunghwa Chemical Synthesis & Biotech | 3.07B |
| Genovate Biotechnology | 2.99B |
| GlycoNex Incorporation | 2.98B |
| Apex Biotechnology | 2.94B |
| TWi Biotechnology | 2.83B |
| HeXun Biosciences | 2.77B |
| Intech Biopharm | 2.74B |